ELF5 is a tumor-suppressor gene for RCC; SLC17A3 is related to the origin of RCC; RALBP1 plays an oncogenic role in RCC; WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway; APOC1 is significantly correlated with RCC tumor size and histological grade, and CRYAB promotes RCC tumor angiogenesis by increasing vascular survival during tube morphogenesis. Here, SLC17A3 is linked to renal cell carcinoma.